BioCatalyst

Litifilimab — catalyst calendar

3 verified catalyst event(s) referencing Litifilimab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-27
in 3mo
ESTIMATED
 READOUT
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whethe
Phase 3 · Lupus Erythematosus, Systemic
 BIIB BIOGEN INC. Litifilimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09-30
in 3mo
ESTIMATED
 READOUT
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whethe
Phase 3 · Lupus Erythematosus, Systemic
 BIIB BIOGEN INC. Litifilimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10-20
in 4mo
ESTIMATED
 READOUT
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Sym
Phase 2/3 · Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
 BIIB BIOGEN INC. Litifilimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.